P
PRME
Prime Medicine
3.430
-0.080-2.28%After Hours: 3.513 +0.083 +2.43%19:36 04/10 EDT
OPEN/PREV CLOSE3.500/3.510
TODAY RANGE3.270-3.543
VOL1.69M
MARKET CAP619.29M
52 WEEK RANGE1.110-6.94
AVG VOL (3M)2.81M
% TURNOVER0.94%
TURNOVER--
P/E (TTM)-2.5368
% RANGE7.78%
EPS(TTM)-1.3521
P/E(FORWARD)-3.4930
P/B5.12
BVPS0.6696
DIVIDEND--
P/S133.46
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP472.01M
SHARES OUTSTANDING180.55M
NEXT EARNINGS05/06-05/11
FREE FLOAT137.61M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·4d ago
Prime Medicine, Inc. (PRME) Receives a Buy from JonesTrading
Dow Jones·03/12 17:23
Prime Medicine Price Target Announced at $11.00/Share by Oppenheimer
TipRanks·03/12 11:46
Oppenheimer bullish on Prime Medicine, initiates with an Outperform
TipRanks·03/12 10:26
Prime Medicine initiated with an Outperform at Oppenheimer
TipRanks·03/04 13:45
Largest borrow rate increases among liquid names
TipRanks·03/04 11:40
Wall Street Analysts Are Neutral on Top Healthcare Picks
Seeking Alpha·03/03 20:38
Prime Medicine GAAP EPS of -$1.35, revenue of $4.63M
Seeking Alpha·03/03 18:22
Prime Medicine slips after Q4 updates
TipRanks·03/03 13:38
Prime Medicine Reports 2025 Results, Advances Gene Editing Pipeline
Reuters·03/03 13:12
Prime Medicine 2025 net loss widens, hurt by higher R&D expenses
TipRanks·03/03 13:07
Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year